>> yeah. >> it is a day of reckoning for eloy orosco. >> a big day for me. i am really nervous. >> he is on his way to a parole hearing. orosco could have his parole reinstated and go home or be sent to prison for 2 1/2 more years to complete his sentence for burglary. he could be isn't to an intermediate sanction facility or ifs, halfway house for parole violators. orosco's parole violations include a fail drug test, and allegations by his sister-in-law he made terroristic threats against her. she has been invited to testify at the hearing. if she shows up, orosco fears he will return to prison. >> i am a repeat offend ter. -- i am a repeat offender. my word isn't taken into consideration. if she shows, i am guilty. she is married to my brother. she has the rest of her life being married to my brother, to face my family. >> he worries if his mother attend the hearing she will find out about his failed drug test. >> i haven't been straight up with my mom. i hate to break her heart. >> the hearing is a tended by orosco's parole officer and run by edna corales

>> eloy orosco finds out if his sister-in-law will testify against him.st -- >> going with the mexican mafia was only supposed to be a temporary thing. i didn't know that was supposed to be like a permanent thing. >> a young man joins a dangerous gang and now faces the possibility of life in prison. yoyour friends have your back. your dog's definitely got your back. but who's got your back when you need legal help? we do. we're legalzoom, and over the last 10 years, we've helped millions of people protect their families and run their businesses. we have the right people on-hand to answer your questions, backed by a trusted network of attorneys. so visit us today for legal help you can count on. legalzoom. legal help is here. but i've managed.e crohn's disease is tough, except that managing my symptoms was all i was doing. and when i finally told my doctor, he said humira is for adults like me who have tried other medications but still experience the symptoms of moderate to severe crohn's disease. and that in clinical studies, the majority of patients on h